Neuronal ceroidolipofuscinosis type 2 (CLN2) disease: Clinical features, diagnosis and an innovative therapeutic opportunity

被引：0
|
作者：
Dallagiacoma, S. [1 ]
Di Donato, I. [1 ]
Sollazzo, M. T. [1 ]
Rufa, A. [1 ]
Specchio, N. [2 ]
Aiello, C. [2 ]
Bertini, E. [3 ]
Tedeschi, G. [4 ]
Dotti, M. T. [1 ]
机构：
[1] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[2] Osped Pediat Bambino Gesu IRCCS Roma, Dipartimento Neurosci, Unita Epilessie Rare & Complesse, Rome, Italy
[3] Osped Pediat Bambino Gesu IRCCS Roma, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy
[4] Univ Campania L Vanvitelli, Dept Med Surg Neurol Metab & Aging Sci, Div Neurol 1, Naples, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO2069
引用
收藏
页码：592 / 593
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study
    Schulz, Angela
    Specchio, Nicola
    Reyes, Emily de los
    Gissen, Paul
    Nickel, Miriam
    Trivisano, Marina
    Aylward, Shawn C.
    Chakrapani, Anupam
    Schwering, Christoph
    Wibbeler, Eva
    Westermann, Lena Marie
    Ballon, Douglas J.
    Dyke, Jonathan P.
    Cherukuri, Anu
    Bondade, Shailesh
    Slasor, Peter
    Pfeffer, Jessica Cohen
    LANCET NEUROLOGY, 2024, 23 (01): : 60 - 70
  • [42] Late infantile neuronal ceroid lipofuscinosis:: Quantitative description of the clinical course in patients with CLN2 mutations
    Steinfeld, R
    Heim, P
    von Gregory, H
    Meyer, K
    Ullrich, K
    Goebel, HH
    Kohlschütter, A
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 112 (04): : 347 - 354
  • [43] Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)
    Gutic, Medo
    Milosavljevic, Milos N.
    Safiye, Teodora
    Milidrag, Ardea
    Jankovic, Slobodan M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (05) : 561 - 570
  • [44] Late Infantile Neuronal Ceroid Lipofuscinosis: Mutations in the CLN2 Gene and Clinical Course in Spanish Patients
    Perez-Poyato, Maria S.
    Pineda Marfa, Merce
    Ferrer Abizanda, Isidre
    Rodriguez-Revenga, Laia
    Cusi Sanchez, Victoria
    Martinez Gonzalez, Maria J.
    Eiris Punal, Jesus
    Verdu Perez, Alfonso
    Garcia Gonzalez, M. Mar
    Martinez Bermejo, Antonio
    Martin Hernandez, Elena
    Coll Rosell, M. Josep
    Gort, Laura
    Mila, Montserrat
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (04) : 470 - 478
  • [45] A proposed model for the late-infantile neuronal ceroid lipofuscinosis (Batten disease) protein CLN2
    Orry, A
    Wallace, BA
    PROTEIN AND PEPTIDE LETTERS, 1999, 6 (01): : 1 - 5
  • [46] Intrafamilial variability in late-onset CLN2 disease
    Goobie, Sharan
    Bujold, Jillian
    Dyack, Sarah
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S66 - S67
  • [47] An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy
    Dorothy A. Thompson
    Siân E. Handley
    Robert H. Henderson
    Oliver R. Marmoy
    Paul Gissen
    Eye, 2021, 35 : 2438 - 2448
  • [48] Molecular basis of the neuronal ceroid lipofuscinoses:: Mutations in CLN1, CLN2, CLN3, and CLN5
    Mole, SE
    Mitchison, HM
    Munroe, PB
    HUMAN MUTATION, 1999, 14 (03) : 199 - 215
  • [49] Evolved AAV Capsids for Gene Therapy of CLN2 Disease
    Tecedor, Luis
    Chen, Yong Hong
    Ranum, Paul T.
    Megan, Keiser S.
    Leib, David E.
    Cheng, Congsheng
    Lysenko, Elena
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2022, 30 (04) : 128 - 129
  • [50] Provoked seizures might lead to a significant diagnosis delay in CLN2
    Rener-Primec, Zvonka
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2022, 40 : A4 - A5
12345